Mr. Kenneth Kabagambe
Executive Director, National Organization for People Living with Hepatitis B (NOPLHB)
My work started in 2012 when I realized that I was hepatitis B positive. This was at the time I had a lost a colleague to hepatitis B. In the first days, it was so frustrating, but then I treated it as an opportunity since I was not ill. I realized there are so many people out there living with hepatitis B, but many do not know they have hepatitis B… I thought I should mobilize the patients and communities that are facing the same challenges.
Mr. Kabagambe is the Founder and Executive Director of the National Organization for People Living with Hepatitis B (NOPLHB), the only patient driven non-governmental organization advocating for the rights of Hepatitis B patients in Uganda. He has been a tireless advocate for people living with hepatitis B and his efforts have directly led to expanded national and regional government commitments to hepatitis prevention, testing, and treatment across the region.
In 2014, he staged a hepatitis B charity walk to rally domestic political support, inviting high-level political figures, including Parliament members, the Prime Minister, and the President. As a result, the following year, Parliament allocated domestic funding to the hepatitis B program for the first time, at about US$ 3 million annually. Mr. Kabagambe is now a Member of the Hepatitis Technical Working Committee of the Ministry of Health. In 2019, he organized the first African Hepatitis Summit 2019, which convened over 600 regional and global leaders and led to the Egyptian government’s commitment to support HCV treatment for 1 million Africans in 14 countries. The second African Hepatitis Summit is being planned for 2021 in Ethiopia in collaboration with the African Union and World Health Organization African Office.
Mr. Kabagambe is also the Vice President of the African Liver Patients Association (ALPA) in Uganda and founded the Africa Hepatitis Initiative (AHI), a Pan-African organization with a vision of mitigating the impact of viral hepatitis in Africa through collaborations with key stakeholders in viral hepatitis.